Company news

Amphastar Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021

May 5, 2021

Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection

May 2, 2021

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 6th, 2021

April 28, 2021

Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference

April 5, 2021

Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection

March 28, 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020

March 14, 2021

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021

March 7, 2021

Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference

February 25, 2021

Amphastar Announces Approval for Glucagon for Injection Kit, 1mg

December 28, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020

November 5, 2020

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2020

October 28, 2020

Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection

October 5, 2020

Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference

September 2, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020

August 5, 2020

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020

July 29, 2020

Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference

June 18, 2020

Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference

June 11, 2020

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial

June 8, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2020

May 6, 2020

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2020

May 3, 2020

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

April 26, 2020

Amphastar Pharmaceuticals, Inc. Announces Simplification of Management Structure

April 12, 2020

Amphastar Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference

April 8, 2020

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2019

March 11, 2020

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12th, 2020

March 4, 2020

Amphastar Pharmaceuticals Receives FDA Approval for Supplement to its Abbreviated New Drug Application for Sodium Bicarbonate Injection, USP 8.4%, 50mEq/50mL

February 26, 2020

Amphastar Announces the Receipt of a MINOR CRL for Epinephrine Injection, USP 30mg/30mL (1mg/mL) Multiple Dose Vial

January 27, 2020

Amphastar Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference

November 26, 2019

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2019

November 6, 2019

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7th, 2019

October 31, 2019

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 12, 2019

March 6, 2019

← Newer news releases

Calls

The 5 newest of 17 calls. Every call is listed under its year.

Decks

The 5 newest of 30 decks. Every deck is listed under its year.